CD30 prevents T-cell responses to non-lymphoid tissues

Immunological Reviews

Volumn 169, Issue , 1999, Pages 23-29

  Heath, William R ^a   Kurts, Christian ^b   Caminschi, Irina ^a   Carbone, Francis R ^c   Miller, Jacques F A P ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD30 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CELL DESTRUCTION; CELLULAR IMMUNITY; CROSS TOLERANCE; IMMUNOLOGICAL TOLERANCE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD30; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; IMMUNOTHERAPY; INFECTION; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; SELF TOLERANCE; T-LYMPHOCYTES;

EID: 0032798670     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01303.x     Document Type: Review

References (23)

1. 1. Von Boehmer H, Hafen K. Minor but not major histocompatibility antigens of thymus epithelium tolerize precursors of cytolytic T cells. Nature 1986;320:626-628.
2. 2. Bevan MJ. Antigen recognition. Class discrimination in the world of immunology. Nature 1987;325:192-194.
3. 3. Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994;264:961-965.
4. 4. Kurts C, Heath WR, Carbone FR, Allison J, Miller JFAP, Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996;184:923-930.
5. 5. Heath WR, Kurts C, Miller JFAP, Carbone FR. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med 1998;187:1549-1553.
6. 6. Carbone FR, Kurts C, Bennett SR, Miller JF, Heath WR. Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today 1998;19:368-373.
7. + T cell tolerance by cross-presentation of self antigens. Immunol Rev 1998;165:368-373.
8. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 1997;186:2057-2062.
9. + T cells. J Exp Med 1997;186:239-245.
10. + T cell tolerance to parenchymal self antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med 1998;187:1555-1564.
11. 11. Forster I, Lieberam I. Peripheral tolerance of CD4 T cells following local activation in adolescent mice. Eur J Immunol 1996;26:3194-3202.
12. + T cells induced by cross-presentation of self-antigens involves signalling through CD95 (Fas, Apo-1). J Exp Med 1998;188:415-420.
13. 13. Strasser A, Harris AW, Huang DC, Krammer PH, Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 1995;14:6136-6147.
14. 14. Strasser A. Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms. Curr Opin Immunol 1995;7:228-234.
15. 15. Schwab U, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982;299:65-67.
16. 16. Smith CA, et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993;73:1349-1360.
17. 17. Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994;83:2045-2056.
18. 18. Lee SY, Park CG, Choi Y. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med 1996;183:669-674.
19. 19. Telford WG, Nam SY, Podack ER, Miller RA. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals. Cell Immunol 1997;182:125-136.
20. 20. Cerutti A, et al. CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells. Immunity 1998;9:247-256.
21. 21. Wiley SR, Goodwin RG, Smith CA. Reverse signaling via CD30 ligand. J Immunol 1996;157:3635-3639.
22. 22. Vella AT, McCormack JE, Linsley PS, Kappler JW, Marrack P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 1995;2:261-270.
23. 23. Kronin V, et al. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J Immunol 1996;157:3819-3827.